Terms: = Testicular cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
2 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis.
Sugimura J; Foster RS; Cummings OW; Kort EJ; Takahashi M; Lavery TT; Furge KA; Einhorn LH; Teh BT
Clin Cancer Res; 2004 Apr; 10(7):2368-78. PubMed ID: 15073113
[TBL] [Abstract] [Full Text] [Related]
